{"disease":{"id":"crigler-najjar-syndrome","name":"crigler najjar syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05687474","title":"Baby Detect : Genomic Newborn Screening","phase":"","overall_status":"COMPLETED","enrollment_count":6824,"lead_sponsor_name":"Centre Hospitalier Universitaire de Liege","has_results":false},{"nct_id":"NCT03343756","title":"HepaStem Long-Term Safety Registry","phase":"","overall_status":"TERMINATED","enrollment_count":44,"lead_sponsor_name":"Cellaion SA","has_results":false},{"nct_id":"NCT03466463","title":"Gene Therapy for Severe Crigler Najjar Syndrome","phase":"NA","overall_status":"RECRUITING","enrollment_count":17,"lead_sponsor_name":"Genethon","has_results":false},{"nct_id":"NCT03078881","title":"Clinical Assessment Study in Crigler-Najjar Syndrome","phase":"","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Audentes Therapeutics","has_results":false},{"nct_id":"NCT06641154","title":"Gene Therapy for Crigler Najjar Syndrome Type I (AlphaCN)","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":5,"lead_sponsor_name":"Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare","has_results":false},{"nct_id":"NCT06518005","title":"Efficacy and Safety of GNT0003 Following Imlifidase Pre-treatment in Severe Crigler-Najjar Syndrome","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":3,"lead_sponsor_name":"Genethon","has_results":false},{"nct_id":"NCT03223194","title":"Gene Transfer Clinical Study in Crigler-Najjar Syndrome","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Audentes Therapeutics","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}